Search

Your search keyword '"Marso, Steven P."' showing total 687 results

Search Constraints

Start Over You searched for: Author "Marso, Steven P." Remove constraint Author: "Marso, Steven P."
687 results on '"Marso, Steven P."'

Search Results

51. Transradial approach for coronary chronic total occlusion interventions: Insights from a contemporary multicenter registry

60. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention

61. Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes:a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials

67. Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes

70. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

71. Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous coronary intervention: An analysis of 25,223 patients over 20 years

72. Does clinical presentation affect outcome among patients with acute coronary syndromes undergoing percutaneous coronary intervention? Insights from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study

75. Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN‐CTO registry

76. Management of Percutaneous Coronary Intervention Complications

93. Development of a hypoglycaemia risk score to identify high‐risk individuals with advanced type 2 diabetes in DEVOTE.

94. Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE.

95. Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

96. Liraglutide and renal outcomes in type 2 diabetes

97. LEADER 3—Lipase and Amylase Activity in Subjects With Type 2 Diabetes

99. Cardiovascular Safety and Severe Hypoglycemia Benefit of Insulin Degludec vs. Insulin Glargine U100 in Older Patients (≥65 Years) with Type 2 Diabetes: Observations From DEVOTE

100. Rates of Major Adverse Cardiovascular Events and Mortality with Basal Insulin by Liraglutide Use: A DEVOTE Subanalysis

Catalog

Books, media, physical & digital resources